External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia.


Journal

Journal of global health
ISSN: 2047-2986
Titre abrégé: J Glob Health
Pays: Scotland
ID NLM: 101578780

Informations de publication

Date de publication:
2021
Historique:
entrez: 5 11 2021
pubmed: 6 11 2021
medline: 9 11 2021
Statut: epublish

Résumé

Existing scores to identify children at risk of hospitalized pneumonia-related mortality lack broad external validation. Our objective was to externally validate three such risk scores. We applied the Respiratory Index of Severity in Children (RISC) for HIV-negative children, the RISC-Malawi, and the Pneumonia Etiology Research for Child Health (PERCH) scores to hospitalized children in the Pneumonia REsearch Partnerships to Assess WHO REcommendations (PREPARE) data set. The PREPARE data set includes pooled data from 41 studies on pediatric pneumonia from across the world. We calculated test characteristics and the area under the curve (AUC) for each of these clinical prediction rules. The RISC score for HIV-negative children was applied to 3574 children 0-24 months and demonstrated poor discriminatory ability (AUC = 0.66, 95% confidence interval (CI) = 0.58-0.73) in the identification of children at risk of hospitalized pneumonia-related mortality. The RISC-Malawi score had fair discriminatory value (AUC = 0.75, 95% CI = 0.74-0.77) among 17 864 children 2-59 months. The PERCH score was applied to 732 children 1-59 months and also demonstrated poor discriminatory value (AUC = 0.55, 95% CI = 0.37-0.73). In a large external application of the RISC, RISC-Malawi, and PERCH scores, a substantial number of children were misclassified for their risk of hospitalized pneumonia-related mortality. Although pneumonia risk scores have performed well among the cohorts in which they were derived, their performance diminished when externally applied. A generalizable risk assessment tool with higher sensitivity and specificity to identify children at risk of hospitalized pneumonia-related mortality may be needed. Such a generalizable risk assessment tool would need context-specific validation prior to implementation in that setting.

Sections du résumé

BACKGROUND BACKGROUND
Existing scores to identify children at risk of hospitalized pneumonia-related mortality lack broad external validation. Our objective was to externally validate three such risk scores.
METHODS METHODS
We applied the Respiratory Index of Severity in Children (RISC) for HIV-negative children, the RISC-Malawi, and the Pneumonia Etiology Research for Child Health (PERCH) scores to hospitalized children in the Pneumonia REsearch Partnerships to Assess WHO REcommendations (PREPARE) data set. The PREPARE data set includes pooled data from 41 studies on pediatric pneumonia from across the world. We calculated test characteristics and the area under the curve (AUC) for each of these clinical prediction rules.
RESULTS RESULTS
The RISC score for HIV-negative children was applied to 3574 children 0-24 months and demonstrated poor discriminatory ability (AUC = 0.66, 95% confidence interval (CI) = 0.58-0.73) in the identification of children at risk of hospitalized pneumonia-related mortality. The RISC-Malawi score had fair discriminatory value (AUC = 0.75, 95% CI = 0.74-0.77) among 17 864 children 2-59 months. The PERCH score was applied to 732 children 1-59 months and also demonstrated poor discriminatory value (AUC = 0.55, 95% CI = 0.37-0.73).
CONCLUSIONS CONCLUSIONS
In a large external application of the RISC, RISC-Malawi, and PERCH scores, a substantial number of children were misclassified for their risk of hospitalized pneumonia-related mortality. Although pneumonia risk scores have performed well among the cohorts in which they were derived, their performance diminished when externally applied. A generalizable risk assessment tool with higher sensitivity and specificity to identify children at risk of hospitalized pneumonia-related mortality may be needed. Such a generalizable risk assessment tool would need context-specific validation prior to implementation in that setting.

Identifiants

pubmed: 34737862
doi: 10.7189/jogh.11.04062
pii: jogh-11-04062
pmc: PMC8542381
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

04062

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2021 by the Journal of Global Health. All rights reserved.

Déclaration de conflit d'intérêts

Competing interests: The authors have completed the ICMJE Declaration of Interest Form (available upon request from the corresponding author), and declare no conflicts of interest. YBN is staff member of the World Health Organization.

Références

Malar J. 2007 Dec 19;6:168
pubmed: 18093319
PLoS One. 2012;7(1):e27793
pubmed: 22238570
Clin Infect Dis. 2017 Aug 15;65(4):604-612
pubmed: 28605562
Arch Dis Child. 2012 Apr;97(4):336-42
pubmed: 22267369
Pediatrics. 2012 Apr;129(4):701-8
pubmed: 22392179
Pediatr Infect Dis J. 2018 Aug;37(8):743-748
pubmed: 29278608
Lancet. 2015 Jan 31;385(9966):430-40
pubmed: 25280870
Pediatr Infect Dis J. 2000 May;19(5):424-32
pubmed: 10819338
Lancet Glob Health. 2018 Jan;6(1):e74-e83
pubmed: 29241618
Pediatr Pulmonol. 2016 Jun;51(6):588-95
pubmed: 26613245
Lancet. 2015 Dec 5;386(10010):2275-86
pubmed: 26361942
PLoS One. 2014 Mar 25;9(3):e92968
pubmed: 24667695
J Pediatr. 2017 Mar;182:375-377.e2
pubmed: 27939107
PLoS One. 2019 Jun 20;14(6):e0214583
pubmed: 31220085
Public Health Nutr. 2016 Oct;19(14):2513-20
pubmed: 27049813
Am J Clin Nutr. 2013 Jun;97(6):1387-94
pubmed: 23636236
Lancet. 2005 Jan 1-7;365(9453):43-52
pubmed: 15643700
Lancet Infect Dis. 2020 Jan;20(1):60-79
pubmed: 31678026
High Alt Med Biol. 2020 Jun;21(2):114-125
pubmed: 32239983
Lancet. 2019 Aug 31;394(10200):757-779
pubmed: 31257127
Clin Infect Dis. 2017 Jun 15;64(suppl_3):S378-S386
pubmed: 28575375
BMJ Glob Health. 2020 Aug;5(8):
pubmed: 32792409
Ann Am Thorac Soc. 2016 Jul;13(7):1123-8
pubmed: 27159648
Lancet. 2013 Apr 20;381(9875):1380-1390
pubmed: 23369797
Pediatrics. 2017 Sep;140(3):
pubmed: 28835381
Lancet Glob Health. 2019 Jun;7(6):e721-e734
pubmed: 31097276
N Engl J Med. 2020 Jul 2;383(1):13-23
pubmed: 32609979
Lancet. 2005 Mar 26-Apr 1;365(9465):1139-46
pubmed: 15794968
PLoS One. 2016 Dec 28;11(12):e0168126
pubmed: 28030608
Lancet HIV. 2019 Dec;6(12):e831-e859
pubmed: 31439534
J Infect. 2016 Nov;73(5):393-401
pubmed: 27519619
Clin Infect Dis. 2020 Mar 3;70(6):1050-1057
pubmed: 31111870
PLoS One. 2019 Jun 13;14(6):e0217570
pubmed: 31194750
Curr Infect Dis Rep. 2019 Mar 5;21(3):10
pubmed: 30834468
BMJ Open. 2020 Oct 19;10(10):e035045
pubmed: 33077558
N Engl J Med. 2003 Oct 2;349(14):1341-8
pubmed: 14523142
Pediatr Infect Dis J. 2013 Nov;32(11):1175-9
pubmed: 23694836
BMJ. 2008 Jan 12;336(7635):80-4
pubmed: 18182412
J Glob Health. 2015 Dec;5(2):050418
pubmed: 26528392
N Engl J Med. 2020 Dec 17;383(25):2477-2478
pubmed: 33326721
Clin Infect Dis. 2005 Apr 15;40(8):1079-86
pubmed: 15791504

Auteurs

Chris A Rees (CA)

Division of Pediatric Emergency Medicine, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.

Shubhada Hooli (S)

Section of Pediatric Emergency Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.

Carina King (C)

Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden and Institute for Global Health, University College London, London, UK.

Eric D McCollum (ED)

Global Program in Respiratory Sciences, Eudowood Division of Pediatric Respiratory Sciences, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, USA and Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA.

Tim Colbourn (T)

Institute for Global Health, University College London, London, UK.

Norman Lufesi (N)

Ministry of Health, Lilongwe, Malawi.

Charles Mwansambo (C)

Ministry of Health, Lilongwe, Malawi.

Marzia Lazzerini (M)

WHO Collaborating Centre for Maternal and Child Health, Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy.

Shabir Ahmed Madhi (SA)

South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.

Clare Cutland (C)

South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.

Marta Nunes (M)

South African Medical Research Council: Vaccines and Infectious Diseases Analytics Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa.

Bradford D Gessner (BD)

Pfizer Vaccines, Collegeville, Pennsylvania, USA.

Sudha Basnet (S)

Center for Intervention Science in Maternal and Child Health, University of Bergen, Norway.

Cissy B Kartasasmita (CB)

Department of Child Health, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.

Joseph L Mathew (JL)

Pediatric Pulmonology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Syed Mohammad Akram Uz Zaman (SMAU)

Liverpool School of Tropical Medicine, Liverpool, UK.

Glaucia Paranhos-Baccala (G)

Fondation Merieux, Lyon, France.

Shinjini Bhatnagar (S)

Translational Health Science and Technology Institute, Faridabad, India.

Nitya Wadhwa (N)

Translational Health Science and Technology Institute, Faridabad, India.

Rakesh Lodha (R)

All India Institute of Medical Sciences, New Delhi, India.

Satinder Aneja (S)

School of Medical Sciences & Research, Sharda University, Greater Noida, India.

Mathuram Santosham (M)

Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.

Valentina S Picot (VS)

Fondation Merieux, Lyon, France.

Mariam Sylla (M)

Gabriel Touré Hospital, Department of Pediatrics, Bamako, Mali.

Shally Awasthi (S)

King George's Medical University, UP, Department of Pediatrics, Lucknow, India.

Ashish Bavdekar (A)

KEM Hospital Pune, Department of Pediatrics, Pune, India.

Jean-William Pape (JW)

GHESKIO, Centre GHESKIO, Port au Prince, Haiti.

Vanessa Rouzier (V)

GHESKIO, Department of Pediatrics, Port au Prince, Haiti.

Monidarin Chou (M)

University of Health Sciences Faculty of Medicine, Rodolph Mérieux Laboratory, Phom Phen, Cambodia.

Mala Rakoto-Andrianarivelo (M)

Centre d'Infectiologie Charles Mérieux, Antanarivo, Madagascar.

Jianwei Wang (J)

Chinese Academy of Medical Sciences & Peking Union, Medical College Institute of Pathogen Biology, MOH Key Laboratory of Systems Biology of Pathogens and Dr Christophe Mérieux Laboratory, Beijing, China.

Pagbajabyn Nymadawa (P)

Mongolian Academy of Sciences, Academy of Medical Sciences, Ulaanbaatar, Mongolia.

Philippe Vanhems (P)

Hospices Civils de Lyon, Infection Control Unit; CIRI, Centre International de Recherche en Infectiologie, (Team PHE3ID), Université Claude Bernard Lyon, Lyon, France.

Graciela Russomando (G)

Universidad Nacional de Asuncion, Instituto de Investigaciones en Ciencias de la Salud, San Lorenzo, Paraguay.

Rai Asghar (R)

Rawalpindi Medical College, Rawalpindi, Pakistan.

Salem Banajeh (S)

Sana'a University, Sana'a, Yemen.

Imran Iqbal (I)

Nishtar Medical College, Multan, Pakistan.

William MacLeod (W)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Irene Maulen-Radovan (I)

Instituto Nactional de Pediatria Division de Investigacion Insurgentes, Mexico City, Mexico.

Greta Mino (G)

Children's Hospital Dr Francisco de Ycaza Bustamante, Head of Department, Infectious diseases, Guayaquil, Ecuador.

Samir Saha (S)

Dhaka Shishu Hospital, Dhaka, Bangladesh.

Sunit Singhi (S)

Medanta, The Medicity, Gurgaon, India.

Donald M Thea (DM)

Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.

Alexey W Clara (AW)

US Centers for Disease Control, Central American Region, Guatemala City, Guatemala.

Harry Campbell (H)

Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, Scotland.

Harish Nair (H)

Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, Scotland.

Jennifer Falconer (J)

Institute for Global Health and Development, Queen Margaret University, Edinburgh, Scotland.

Linda J Williams (LJ)

Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, Scotland.

Margaret Horne (M)

Centre for Global Health, Usher Institute, The University of Edinburgh, Edinburgh, Scotland.

Tor Strand (T)

Research Department, Innlandet Hospital Trust, Lillehammer, Norway.

Shamim A Qazi (SA)

Department of Maternal, Newborn, Child and Adolescent Health (Retired), World Health Organization, Geneva, Switzerland.

Yasir B Nisar (YB)

Department of Maternal, Newborn, Child and Adolescent Health and Ageing, World Health Organization, Geneva, Switzerland.

Mark I Neuman (MI)

Division of Emergency Medicine, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH